214000-16-5Relevant articles and documents
MACROCYCLIC ACTIVIN-LIKE RECEPTOR KINASE INHIBITORS
-
Page/Page column 100, (2016/10/04)
The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of Activin-like receptor kinases, more in particular ALK1 and/or ALK2 and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of ALK1-kinase and/or ALK2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.
Chemoselective alkynylation of N-sulfonylamides versus amides and carbamates-Synthesis of tetrahydropyrazines
Aubineau, Thomas,Cossy, Janine
, p. 3303 - 3305 (2013/06/04)
The chemoselective alkynylation of N-sulfonylamides versus amides and carbamates using TMS-EBX as an alkynylating agent leads to the formation of non-symmetrical tetrahydropyrazines from orthogonally protected diamines. The Royal Society of Chemistry 2013
Concise preparation of 8-trifluoromethyltetrahydro-6H-pyrido [1,2-a] pyrazine-6-one
Kothandaraman, Shankaran,Guiadeen, Deodialsingh,Butora, Gabor,Doss, George,Mills, Sander G.,MacCoss, Malcolm,Yang, Lihu
scheme or table, p. 4050 - 4053 (2009/10/11)
Methodology to rapidly and efficiently assemble 8-trifluoromethyltetrahydro-6H-pyrido [1,2-a] pyrazine-6-one (11) has been developed and its general applicability has been demonstrated.